Perfect Medical Health Management Limited (HKG:1830), might not be a large cap stock, but it saw significant share price movement during recent months on the SEHK, rising to highs of HK$4.27 and falling to the lows of HK$3.45. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Perfect Medical Health Management's current trading price of HK$3.45 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let's take a look at Perfect Medical Health Management's outlook and value based on the most recent financial data to see if there are any catalysts for a price change.
View our latest analysis for Perfect Medical Health Management
Is Perfect Medical Health Management Still Cheap?
According to my price multiple model, where I compare the company's price-to-earnings ratio to the industry average, the stock currently looks expensive. In this instance, I've used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock's cash flows. I find that Perfect Medical Health Management's ratio of 14.05x is above its peer average of 6.9x, which suggests the stock is trading at a higher price compared to the Consumer Services industry. But, is there another opportunity to buy low in the future? Since Perfect Medical Health Management's share price is quite volatile, this could mean it can sink lower (or rise even further) in the future, giving us another chance to invest. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.
What does the future of Perfect Medical Health Management look like?
SEHK:1830 Earnings and Revenue Growth September 27th 2022
Future outlook is an important aspect when you're looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. Perfect Medical Health Management's earnings over the next few years are expected to double, indicating a very optimistic future ahead. This should lead to stronger cash flows, feeding into a higher share value.
What This Means For You
Are you a shareholder? It seems like the market has well and truly priced in 1830's positive outlook, with shares trading above industry price multiples. At this current price, shareholders may be asking a different question – should I sell? If you believe 1830 should trade below its current price, selling high and buying it back up again when its price falls towards the industry PE ratio can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.
Are you a potential investor? If you've been keeping tabs on 1830 for some time, now may not be the best time to enter into the stock. The price has surpassed its industry peers, which means it is likely that there is no more upside from mispricing. However, the optimistic prospect is encouraging for 1830, which means it's worth diving deeper into other factors in order to take advantage of the next price drop.
With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. While conducting our analysis, we found that Perfect Medical Health Management has 2 warning signs and it would be unwise to ignore them.
If you are no longer interested in Perfect Medical Health Management, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
完美醫療健康管理有限公司(HKG:1830)可能不是一隻大盤股,但它在聯交所的股價在最近幾個月大幅波動,升至4.27港元的高點,並跌至3.45港元的低點。一些股價波動可以讓投資者有更好的機會買入股票,並有可能以更低的價格買入。一個需要回答的問題是,完美醫療健康管理公司目前3.45港元的交易價格是否反映了小盤股的實際價值?或者,它目前被低估了,為我們提供了買入的機會?讓我們根據最新的財務數據來看看Perfect Medical Health Management的前景和價值,看看是否有任何推動價格變化的催化劑。
查看我們的最新分析,完善醫療健康管理
完美的醫療健康管理仍然便宜嗎?
根據我的市盈率模型,我將該公司的市盈率與行業平均水平進行比較,目前該股看起來很貴。在這種情況下,考慮到沒有足夠的信息來可靠地預測股票的現金流,我使用了市盈率(PE)。我發現完美醫療健康管理的比率為14.05倍,高於6.9倍的同行平均水平,這表明該股的交易價格高於消費者服務行業。但是,未來有沒有另一個低位買入的機會?由於完美醫療健康管理公司的股價波動很大,這可能意味着它未來可能會下跌(或進一步上漲),給我們另一個投資機會。這是基於其較高的貝塔係數,這是衡量該股相對於市場其他股票波動程度的一個很好的指標。
完美醫療健康管理的未來是什麼樣子的?
聯交所:1830盈利及收入增長2022年9月27日
當你考慮購買一隻股票時,未來前景是一個重要的方面,特別是如果你是一個尋求投資組合增長的投資者。以低廉的價格收購一家前景穩健的偉大公司永遠是一筆不錯的投資,所以讓我們也來看看該公司的未來預期。完美醫療健康管理公司未來幾年的收益預計將翻一番,預示着非常樂觀的未來。這應該會帶來更強勁的現金流,從而推動更高的股價。
這對你意味着什麼
你是股東嗎?市場似乎已經很好地、真實地反映了1830年的積極前景,股票交易價格高於行業市盈率。在目前的價格下,股東們可能會問一個不同的問題--我應該賣出嗎?如果你認為1830應該在當前價格以下交易,那麼當其價格跌至行業水平時,逢高拋售並再次買入,市盈率可能是有利可圖的。但在你做出這個決定之前,先看看它的基本面是否發生了變化。
你是潛在的投資者嗎?如果你已經關注1830有一段時間了,現在可能不是買入這隻股票的最佳時機。這一價格已經超過了業內同行,這意味着錯誤定價很可能不會帶來更多的好處。然而,樂觀的前景對1830來説是令人鼓舞的,這意味着為了利用下一次價格下跌,值得更深入地研究其他因素。
考慮到這一點,除非我們對風險有透徹的瞭解,否則我們不會考慮投資股票。在進行分析時,我們發現完美醫療健康管理具有2個警告標誌忽視它們是不明智的。
如果您對完美醫療健康管理不再感興趣,您可以使用我們的免費平臺查看我們的其他50多隻具有高增長潛力的股票。
對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。